Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
NCT03607409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2019-08-08
Summary
To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol
Conditions
Sponsors & Collaborators
-
Ansh Labs
collaborator UNKNOWN -
ART Fertility Clinics LLC
lead OTHER
Principal Investigators
-
Barbara Lawrenz, PhD · ART Fertility Clinics LLC
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-09
- Primary Completion
- 2019-01-29
- Completion
- 2019-07-04
Countries
- United Arab Emirates
Study Locations
More Related Trials
-
The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
NCT03209687 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
NCT03300518 ·Status: COMPLETED ·Phase: NA
-
Inhibin B/AFC Ratio for Ovarian Response
NCT06292806 ·Status: NOT_YET_RECRUITING
-
Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle?
NCT03398603 ·Status: COMPLETED
-
AMH and Dosing Regimens for Initial IVF Stimulation Protocols
NCT03098199 ·Status: COMPLETED ·Phase: NA
-
Optimizing Ovulation Induction in the Poor Responder
NCT01200537 ·Status: WITHDRAWN ·Phase: NA
-
IVM for Patients With Low Ovarian Response. Does it Improve IVFoutcomes and Does it Improve the Following IVF Cycle?
NCT02498210 ·Status: UNKNOWN ·Phase: NA
-
Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve
NCT02128360 ·Status: UNKNOWN ·Phase: NA
-
Antagonist Protocol in IVF
NCT02335736 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .
NCT03832894 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluating the AMH Levels During Natural Cycle
NCT03106272 ·Status: COMPLETED
-
Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks
NCT01887652 ·Status: COMPLETED ·Phase: NA
-
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
NCT01037699 ·Status: COMPLETED ·Phase: PHASE3
-
A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
NCT04417569 ·Status: COMPLETED
-
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
NCT00439829 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
NCT05567731 ·Status: COMPLETED ·Phase: NA
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
NCT06879002 ·Status: NOT_YET_RECRUITING
-
GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response
NCT03134690 ·Status: COMPLETED ·Phase: NA
-
Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo
NCT04539067 ·Status: UNKNOWN ·Phase: PHASE2
-
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
NCT06146413 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trigger Time in Advanced Maternal Age Patients With Low AMH
NCT03740880 ·Status: TERMINATED ·Phase: NA
-
Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure
NCT02329197 ·Status: UNKNOWN ·Phase: PHASE4